Aptose Biosciences Inc (APTO)
1.20
+0.01
(+0.84%)
USD |
NASDAQ |
May 03, 16:00
1.21
+0.01
(+0.83%)
After-Hours: 20:00
Aptose Biosciences Max Drawdown (5Y): 99.14% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.14% |
| March 31, 2024 | 98.96% |
| February 29, 2024 | 98.68% |
| January 31, 2024 | 98.60% |
| December 31, 2023 | 98.41% |
| November 30, 2023 | 98.41% |
| October 31, 2023 | 98.41% |
| September 30, 2023 | 97.96% |
| August 31, 2023 | 97.70% |
| July 31, 2023 | 97.70% |
| June 30, 2023 | 96.69% |
| May 31, 2023 | 95.44% |
| April 30, 2023 | 95.16% |
| March 31, 2023 | 95.16% |
| February 28, 2023 | 95.16% |
| January 31, 2023 | 95.16% |
| December 31, 2022 | 95.16% |
| November 30, 2022 | 94.88% |
| October 31, 2022 | 94.88% |
| September 30, 2022 | 93.97% |
| August 31, 2022 | 92.09% |
| July 31, 2022 | 91.75% |
| June 30, 2022 | 91.75% |
| May 31, 2022 | 89.43% |
| April 30, 2022 | 88.67% |
| Date | Value |
|---|---|
| March 31, 2022 | 90.69% |
| February 28, 2022 | 91.41% |
| January 31, 2022 | 92.70% |
| December 31, 2021 | 92.70% |
| November 30, 2021 | 92.70% |
| October 31, 2021 | 92.70% |
| September 30, 2021 | 92.70% |
| August 31, 2021 | 92.70% |
| July 31, 2021 | 92.70% |
| June 30, 2021 | 92.70% |
| May 31, 2021 | 92.70% |
| April 30, 2021 | 92.70% |
| March 31, 2021 | 92.70% |
| February 28, 2021 | 92.70% |
| January 31, 2021 | 92.70% |
| December 31, 2020 | 92.70% |
| November 30, 2020 | 92.70% |
| October 31, 2020 | 92.70% |
| September 30, 2020 | 92.70% |
| August 31, 2020 | 92.70% |
| July 31, 2020 | 92.70% |
| June 30, 2020 | 92.70% |
| May 31, 2020 | 92.70% |
| April 30, 2020 | 92.70% |
| March 31, 2020 | 92.70% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
88.67%
Minimum
Apr 2022
99.14%
Maximum
Apr 2024
93.84%
Average
92.70%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| Acasti Pharma Inc | 98.73% |
| Aurinia Pharmaceuticals Inc | 87.58% |
| Edesa Biotech Inc | 99.58% |
| Lexaria Bioscience Corp | 98.90% |
| Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -64.27 |
| Beta (5Y) | 1.358 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 85.23% |
| Historical Sharpe Ratio (5Y) | -0.5766 |
| Historical Sortino (5Y) | -1.415 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.93% |